IDEAYA Biosciences Balance Sheet
NASDAQ: IDYAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
IDEAYA Biosciences financial position
At the end of fiscal 2025, IDEAYA Biosciences reported total assets of $1.11 billion, down 1.3% from a year earlier against total liabilities of $86.4 million. Shareholders' equity stood at $1.02 billion, or 92.2% of assets. The company held $112.8 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 11.34, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
IDEAYA Biosciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 112.83M | 84.38M | 157.02M | 68.63M | 92.05M | 72.04M | 34.07M | 20.50M | 5.96M |
| Short-Term Investments | 526.56M | 591.94M | 368.10M | 296.20M | 154.72M | 211.55M | 64.89M | 69.46M | — |
| Receivables | — | 3.00K | 18.00K | 211.00K | 1.10M | 1.88M | — | — | — |
| Total Current Assets | 666.73M | 689.71M | 532.63M | 370.45M | 251.00M | 288.61M | 101.65M | 90.67M | — |
| Property, Plant & Equipment | 8.22M | 8.97M | 6.16M | 6.51M | 4.76M | 4.27M | 4.64M | 5.15M | — |
| Long-Term Investments | 410.30M | 405.83M | 107.49M | 8.32M | 121.29M | 0 | 1.53M | — | — |
| Total Assets | 1.11B | 1.12B | 649.32M | 387.97M | 381.35M | 298.27M | 113.00M | 96.54M | — |
| Accounts Payable | 17.58M | 15.42M | 6.60M | 4.28M | 2.10M | 953.00K | 709.00K | 1.42M | — |
| Total Current Liabilities | 58.81M | 46.07M | 27.10M | 31.72M | 45.16M | 38.64M | 6.94M | 5.41M | — |
| Total Liabilities | 86.39M | 64.94M | 28.23M | 38.51M | 79.83M | 100.00M | 12.60M | 7.10M | — |
| Shareholders' Equity | 1.02B | 1.06B | 621.09M | 349.45M | 301.51M | 198.27M | 100.40M | -48.95M | -15.74M |
| Retained Earnings | -736.54M | -622.84M | -348.36M | -235.40M | -176.75M | -126.99M | -92.49M | -50.52M | — |
| Net Cash (Debt) | 639.39M | 676.32M | 525.11M | 364.83M | 246.77M | 283.58M | 98.96M | 89.96M | 5.96M |
| Shares Outstanding | 87.80M | 86.50M | 65.04M | 48.19M | 38.53M | 29.54M | 20.34M | 1.34M | — |
This table shows 9 annual periods of IDEAYA Biosciences's balance sheet, from FY 2025 back to FY 2017, across 14 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IDYA's reporting calendar. What is a balance sheet?